Admir Malaj

Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries

Tomasz Bochenek, Vafa Abilova, Ali Alkan et al. · Frontiers in Pharmacology · 2018 · 111 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmaceutical Care +15

Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications

Brian Godman, Andrew Hill, Steven Simoens et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2021 · 73 citations · Full text

Pharmacy, Oncology, Pharmaceutical Policy +17

Are pharmacists’ good knowledge and awareness on antibiotics taken for granted? The situation in Albania and future implications across countries

Iris Hoxha, Admir Malaj, Besmira Kraja et al. · Journal of Global Antimicrobial Resistance · 2018 · 72 citations

Pharmacy, Community Pharmacy, Pharmacy Practice +14

The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures

Evelien Moorkens, Brian Godman, Isabelle Huys et al. · Frontiers in Pharmacology · 2021 · 68 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacology +17

Pricing of oral generic cancer medicines in 25 European countries; findings and implications

Brian Godman, Andrew Hill, Steven Simoens et al. · Generics and Biosimilars Initiative Journal · 2019 · 45 citations · Full text

Pharmacy, Oncology, Pharmaceutical Policy +17